Each week, we bring you a curated selection of the most noteworthy Private Equity transactions across Europe and North America, carefully extracted from the Arx Database. These insights provide a unique perspective on key market trends and highlight strategic investment opportunities.
Whether you are an investor, advisor, or M&A professional, our weekly selections are designed to deliver relevant information to keep you at the forefront of industry developments.
For more details on fund activities and to access exclusive resources, feel free to subscribe to our newsletters or explore the Arx Database directly.
Equistone Partners Europe
Add-on: IT Consulting Firm TIMETOACT GROUP Acquires JOIN(+)
Majority-owned by Equistone Partners Europe, TIMETOACT GROUP (€320 million of revenue in 2023, North Rhine-Westphalia / DEU), a provider of IT consulting as well as a wide range of IT services such as cloud transformation, data engineering, custom application development and much more, acquires JOIN(+) (Bade-Wurtemberg / DEU), an IT consulting firm specializing in Big Data and AI. The acquisition will strengthen the group’s service portfolio, allowing it to expand its expertise in the field of data analytics and AI, while increasing its presence in the DACH region. JOIN(+)’s managers, Erich Anhut and Jürgen Lutz, will continue to lead the company to facilitate its integration into TIMETOACT GROUP.
Cathay Capital
Acquisition: Pharmaceutical Company, Aqemia, Raises $38 Million
Cathay Capital, through Cathay Innovation, invests in Aqemia (Île-de-France / FRA), a next-generation pharmaceutical company that uses quantum physics and generative AI to generate a pipeline that transforms and extends the drug discovery process, enabling the rapid development of innovative new drug candidates for severe diseases. The investment was made as part of a $38 million round of financing, in which historical investors Wendel, Bpifrance Large Venture, Eurazeo and Elaia Partners also participated. With this new financing, Aqemia will be able to move on to the clinical trials stage for its drug candidates.
Cathay Capital, press release
Antea Participaties
Exit: Antea Participaties Sells Electrical Installation Maintenance Company Gouweloos
Majority shareholder since 2021, Antea Participaties announces the sale of Gouweloos (South Holland / NLD), a provider of installation, maintenance and management services for electrical installations, which has been acquired by VDK Groep (Overijssel / NLD), a company owned by EMK Capital that specializes in installation, painting, finishing and project design work. This sale illustrates Antea’s strategic approach of investing in promising companies and optimizing their value before selling them.
Antea Participaties, press release
Gyrus Capital
Fundraising: Gyrus Capital Raises €600 Million for its Continuation Fund
Gyrus Capital announces that it has raised €600 million for its continuation fund, dedicated to continuing its investment in Essential Pharma (£18.8 million of revenue in 2023, South-East / ENG), a biopharmaceutical company engaged in the production of generic drugs for disorders related to neurology, gastroenterology, ophthalmology, dermatology, gynecology, as well as infectious and respiratory diseases. This transaction will strengthen Essential Pharma’s ability to provide essential medicines to patients, and extend its reach into the field of rare diseases. As a reminder, Gyrus Capital acquired the company in 2020. Note that Essential Pharma is also supported by Headway Capital and Connection Capital.
Gyrus Capital, press release